ZNF236 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.101900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.590200E-01
Normal-vs-Stage2
3.104700E-03
Normal-vs-Stage3
1.132780E-01
Normal-vs-Stage4
2.118600E-01
Stage1-vs-Stage2
1.361620E-01
Stage1-vs-Stage3
3.865800E-02
Stage1-vs-Stage4
5.380600E-01
Stage2-vs-Stage3
8.154400E-02
Stage2-vs-Stage4
8.451200E-01
Stage3-vs-Stage4
2.367000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.936500E-03
Normal-vs-AfricanAmerican
1.315400E-01
Normal-vs-Asian
3.151500E-02
Caucasian-vs-AfricanAmerican
4.806000E-01
Caucasian-vs-Asian
1.756000E-01
AfricanAmerican-vs-Asian
2.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.596000E-03
Normal-vs-Female
1.001990E-02
Male-vs-Female
2.934800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.617000E-01
Normal-vs-Age(41-60Yrs)
2.203500E-02
Normal-vs-Age(61-80Yrs)
3.757200E-03
Normal-vs-Age(81-100Yrs)
1.151540E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.344200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.973200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.026800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.463600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.918000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.104430E-02
Normal-vs-Daily Drinker
2.776900E-03
Normal-vs-Weekly Drinker
1.040110E-02
Normal-vs-Occasional Drinker
3.517700E-02
Normal-vs-Social Drinker
1.475630E-01
Non Drinker-vs-Daily Drinker
4.118200E-01
Non Drinker-vs-Weekly Drinker
7.851400E-01
Non Drinker-vs-Occasional Drinker
4.855000E-01
Non Drinker-vs-Social Drinker
5.251800E-02
Daily Drinker-vs-Weekly Drinker
6.465800E-01
Daily Drinker-vs-Occasional Drinker
1.499450E-01
Daily Drinker-vs-Social Drinker
9.302900E-03
Weekly Drinker-vs-Occasional Drinker
3.811600E-01
Weekly Drinker-vs-Social Drinker
4.940100E-02
Occasional Drinker-vs-Social Drinker
2.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.448300E-02
Normal-vs-Grade 2
9.095000E-03
Normal-vs-Grade 3
6.176500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.667800E-01
Grade 1-vs-Grade 3
9.642200E-01
Grade 1-vs-Grade 4
5.448300E-02
Grade 2-vs-Grade 3
2.191800E-01
Grade 2-vs-Grade 4
9.095000E-03
Grade 3-vs-Grade 4
6.176500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.744390E-03
Normal-vs-NonDiabetic
3.336100E-03
Diabetic-vs-NonDiabetic
2.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.241600E-03
Normal-vs-NoPancreatitis
3.640700E-03
Pancreatitis-vs-NoPancreatitis
3.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.020300E-02
Normal-vs-N1
2.698600E-03
N0-vs-N1
9.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.043400E-01
Normal-vs-TP53-NonMutant
9.832200E-02
TP53-Mutant-vs-TP53-NonMutant
5.440400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
